NCT05004857

Brief Summary

The primary purpose of this pilot study is to specifically examine the effect of parental reading on the ANS of mother and neonate in the hospital setting. The investigators will examine the effect of live maternal-infant reading on typically developing infants to better understand the physiological benefits of live reading on newborns.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Sep 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Sep 2021Dec 2026

First Submitted

Initial submission to the registry

August 6, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 13, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

September 17, 2021

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

August 9, 2024

Status Verified

August 1, 2024

Enrollment Period

5.2 years

First QC Date

August 6, 2021

Last Update Submit

August 7, 2024

Conditions

Keywords

ReadingNeonatesNew bornsAutonomic nervous system

Outcome Measures

Primary Outcomes (2)

  • Determine the change in vagal tone

    The change in vagal tone from the reading therapy will be measured using MindWare System, where an increase in vagal tone shows positive physiological outcomes in the newborns and mothers.

    20 minutes of reading

  • Determine the change in parasympathetic nervous system response

    The change in parasympathetic nervous system response from the reading therapy will be measured using MindWare System, where an increase in parasympathetic nervous system response shows positive physiological outcomes in the newborns and mothers.

    20 minutes of reading

Study Arms (1)

Patient arm

EXPERIMENTAL

The subject population will be newborn infants admitted to the Newborn Nursery (NN) at Tulane Lakeside Hospital. The investigators are anticipating some mothers can be recruited from the prenatal clinics who expect to deliver at Tulane Hospital during pregnancy as well.

Behavioral: Book reading

Interventions

Book readingBEHAVIORAL

Prior to the first session, a research assistant will place electrodes on the infant and mother so that they study team can gather autonomic nervous system (ANS) response (sympathetic and parasympathetic) non-invasively using MindWare Portable Lab System (MindWare Technologies, Gahanna, Ohio). These electrodes will remain on the infant and mother throughout each session and be removed via adhesive removing pads following each session's data collection. This will minimize discomfort to both parties secondary to electrode removal and minimize risk of skin irritation by leaving electrodes in place for a prolonged period of time. Additional observational data before and after the reading sessions will be collected by the research assistant, including but not limited to: where the session is conducted (mother's arms, bassinet), activity level, vital signs, and any other observed behaviors throughout the session.

Patient arm

Eligibility Criteria

Age1 Minute - 1 Week
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Admitted to the Tulane-Lakeside Hospital Newborn Nursery
  • Corrected gestational age 34 weeks or older
  • No identified hearing disorder
  • Do not have a diagnosed developmental disability (i.e. Down Syndrome)
  • Do not have Fetal Alcohol Syndrome
  • Medically cleared to participate in the study
  • Biological mother able/willing to give consent in English \& complete surveys.

You may not qualify if:

  • Corrected gestational age \< 34 weeks old
  • Has an identified or potential hearing disorder (i.e, failed hearing screen)
  • Has diagnosed developmental disability (i.e. Down syndrome)
  • Has Fetal Alcohol Syndrome
  • Is not medically cleared to participate in the study
  • Biological mother unable/unwilling to give consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tulane University Health Sciences Center

New Orleans, Louisiana, 70112, United States

Location

MeSH Terms

Conditions

Autonomic Nervous System Diseases

Condition Hierarchy (Ancestors)

Nervous System Diseases

Study Officials

  • Meghan Howell, MD, MS

    Tulane University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 6, 2021

First Posted

August 13, 2021

Study Start

September 17, 2021

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

August 9, 2024

Record last verified: 2024-08

Locations